Send the following on WhatsApp
Continue to Chathttps://www.zonebourse.com/cours/action/INCYTE-CORPORATION-9675/actualite/Incyte-annonce-l-approbation-de-la-Commission-europeenne-pour-la-creme-Opzelura-ruxolitinib-da-43604674/?utm_source=whatsapp&utm_medium=social&utm_campaign=share